BACKGROUND: Mannose-binding lectin (MBL) is a circulating collectin that is part of the innate immune response. We explored the serum levels of MBL in persons with different forms of coccidioidomycosis. METHODS: Serum MBL was measured by ELISA from samples obtained from healthy donors with immunity to Coccidioides, and those with various forms of active coccidioidomycosis. Blood cell specimens from a subgroup of subjects with active coccidioidomycosis were examined for single nucleotide polymorphisms of the MBL gene and promoter regions. RESULTS: The control group comprised 29 healthy immune subjects. Patient groups with active coccidioidomycosis consisted of 20 patients with symptomatic primary pulmonary coccidioidomycosis, 26 with non-meningeal disseminated coccidioidomycosis, and nine with coccidioidal meningitis. The group with active coccidioidomycosis was significantly older and more likely to be male than the control group (for both, P < 0.001). The mean +/- SEM level of serum MBL in the healthy controls was 169.4 +/- 28.6 ng/ml, significantly higher than the 79.2 +/- 10.9 ng/ml for all active groups (P < 0.001). Moreover, the active coccidioidomycosis group was significantly more likely to have serum MBL level <or=70 ng/ml compared to the control group (P = 0.001). Genetic analysis in 27 subjects with active coccidioidomycosis revealed marked variation based on race and ethnicity. Among a subgroup of 10 white, non-hispanic men with active coccidioidomycosis, there was a significant association between the H and P haplotypes and MBL levels <or=70 ng/ml (P < 0.036 and P < 0.035, respectively). CONCLUSIONS: These data suggest that there is an association between low serum MBL levels and symptomatic coccidioidomycosis.
BACKGROUND:Mannose-binding lectin (MBL) is a circulating collectin that is part of the innate immune response. We explored the serum levels of MBL in persons with different forms of coccidioidomycosis. METHODS: Serum MBL was measured by ELISA from samples obtained from healthy donors with immunity to Coccidioides, and those with various forms of active coccidioidomycosis. Blood cell specimens from a subgroup of subjects with active coccidioidomycosis were examined for single nucleotide polymorphisms of the MBL gene and promoter regions. RESULTS: The control group comprised 29 healthy immune subjects. Patient groups with active coccidioidomycosis consisted of 20 patients with symptomatic primary pulmonary coccidioidomycosis, 26 with non-meningeal disseminated coccidioidomycosis, and nine with coccidioidal meningitis. The group with active coccidioidomycosis was significantly older and more likely to be male than the control group (for both, P < 0.001). The mean +/- SEM level of serum MBL in the healthy controls was 169.4 +/- 28.6 ng/ml, significantly higher than the 79.2 +/- 10.9 ng/ml for all active groups (P < 0.001). Moreover, the active coccidioidomycosis group was significantly more likely to have serum MBL level <or=70 ng/ml compared to the control group (P = 0.001). Genetic analysis in 27 subjects with active coccidioidomycosis revealed marked variation based on race and ethnicity. Among a subgroup of 10 white, non-hispanic men with active coccidioidomycosis, there was a significant association between the H and P haplotypes and MBL levels <or=70 ng/ml (P < 0.036 and P < 0.035, respectively). CONCLUSIONS: These data suggest that there is an association between low serum MBL levels and symptomatic coccidioidomycosis.
Authors: B D Kirkpatrick; C D Huston; D Wagner; F Noel; P Rouzier; J W Pape; G Bois; C J Larsson; W K Alston; K Tenney; C Powden; J P O'Neill; C L Sears Journal: Clin Infect Dis Date: 2006-06-22 Impact factor: 9.079
Authors: Neil M Ampel; Daniel K Nelson; Lijin Li; Sara O Dionne; Douglas F Lake; Keira A Simmons; Demosthenes Pappagianis Journal: Infect Immun Date: 2005-04 Impact factor: 3.441
Authors: Mudit Vaid; Savneet Kaur; Helen Sambatakou; Taruna Madan; David W Denning; P Usha Sarma Journal: Clin Chem Lab Med Date: 2007 Impact factor: 3.694
Authors: Paulo C Giraldo; Oksana Babula; Ana Katherine S Gonçalves; Iara M Linhares; Rose Luce Amaral; William J Ledger; Steven S Witkin Journal: Obstet Gynecol Date: 2007-05 Impact factor: 7.661
Authors: Waltraud Eder; Walt Klimecki; Lizhi Yu; Erika von Mutius; Josef Riedler; Charlotte Braun-Fahrländer; Dennis Nowak; Fernando D Martinez Journal: J Allergy Clin Immunol Date: 2004-03 Impact factor: 10.793
Authors: Sara O Dionne; Abigail B Podany; Yvette W Ruiz; Neil M Ampel; John N Galgiani; Douglas F Lake Journal: Infect Immun Date: 2006-04 Impact factor: 3.441
Authors: Eric R G Lewis; Victoria R David; Adina L Doyle; Khadijeh Rajabi; Jeffrey A Kiefer; Patrick Pirrotte; Bridget M Barker Journal: Eukaryot Cell Date: 2015-08-14
Authors: Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani Journal: Clin Microbiol Rev Date: 2019-10-16 Impact factor: 26.132
Authors: Marley C Caballero Van Dyke; George R Thompson; John N Galgiani; Bridget M Barker Journal: Front Immunol Date: 2019-09-11 Impact factor: 7.561